GleamWall
中文EN

RXST RxSight, Inc.

Ophthalmic Goods · Nasdaq · SEC CIK 1111485 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-14.3%
TTM net income YoY-49.3%
TTM EPS YoY-46.6%
Revenue 3-yr CAGR16.7%
Net income 3-yr CAGR—

Margins

Gross margin76.1%
Operating margin-50.4%
Net margin-43.8%
FCF margin15.3%
EBITDA margin-47.5%

Returns

ROE-20.1%
ROA-16.4%
ROIC (approx.)-22.4%
Asset turnover0.38x

Leverage & solvency

Liabilities / assets25.1%
Debt / equity0.00x
Current ratio4.20x
Interest coverage-4,389.57x

Cash quality & payout

Operating cash flow / net income-0.44x
Accruals ratio-23.7%
Payout ratio—
Capex / revenue4.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$134.48M$139.93M
Cost of revenue$31.47M$40.98M
Gross profit$103.01M$98.94M
R&D expense$38.55M$34.37M
SG&A expense$112.65M$101.43M
Operating income-$48.19M-$36.86M
Interest expense$19,000$21,000
Pretax income-$38.88M-$27.41M
Income tax$66,000$50,000
Net income-$38.94M-$27.45M
EBITDA-$44.92M-$33.28M
EPS (basic)-0.95-0.71
EPS (diluted)-0.95-0.71
Weighted avg. shares (diluted)40.85M38.87M
Balance sheet
Cash & equivalents$19.95M$17.46M
Short-term investments$208.18M$220.52M
Receivables$23.38M$30.05M
Inventory$31.56M$22.01M
Current assets$287.46M$293.82M
PP&E, net$13.06M$12.41M
Total assets$311.81M$318.56M
Current liabilities$26.25M$25.88M
Total liabilities$36.13M$37.33M
Shareholders' equity$275.68M$281.24M
Shares outstanding41.24M40.43M
Cash flow statement
Operating cash flow-$15.51M-$16.95M
Capital expenditure$3.83M$5.44M
Free cash flow-$19.34M-$22.39M
Investing cash flow$16.89M-$99.31M
Financing cash flow$1.86M$123.32M
Depreciation & amortization$3.27M$3.58M
Stock-based compensation$31.61M$24.64M

Free plan shows the latest 2 periods; Pro shows all 6 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.